Artelo Biosciences announces 1-for-9 reverse stock split

retained text

- Artelo Biosciences (NASDAQ: ARTL) announced on Thursday it will effect a 1-for-9 reverse stock split of its common stock, with trading to begin Aug. 31.
- No fractional shares will be issued, with holders receiving one whole share instead.
- The company said the reverse split is intended to increase its share price and improve marketability and liquidity.
- Pursuant to the transaction, the company expects approximately 547,774 shares of common stock to be outstanding.
- Outstanding warrants and other derivatives will automatically adjust to reflect the reverse split.
- Share -0.92%

document fetched 2026-08-27 13:04 · canonical https://seekingalpha.com/news/4637463-artelo-biosciences-announces-1-forminus-9-reverse-stock-split?feed_item_type=news